EE+ POEM Archive
Clesrovimab reduces risk of respiratory syncytial virus infection and hospitalization (NNT = 51); unclear if it's better than nirsevimab (CLEVER)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Clesrovimab Reduces Risk of Respiratory Syncytial Virus Infection and Hospitalization (NNT = 51); Unclear if It's Better Than Nirsevimab (CLEVER)." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377519/all/Clesrovimab_reduces_risk_of_respiratory_syncytial_virus_infection_and_hospitalization__NNT_=_51_.
Clesrovimab reduces risk of respiratory syncytial virus infection and hospitalization (NNT = 51); unclear if it's better than nirsevimab (CLEVER). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377519/all/Clesrovimab_reduces_risk_of_respiratory_syncytial_virus_infection_and_hospitalization__NNT_=_51_. Accessed December 5, 2025.
Clesrovimab reduces risk of respiratory syncytial virus infection and hospitalization (NNT = 51); unclear if it's better than nirsevimab (CLEVER). (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377519/all/Clesrovimab_reduces_risk_of_respiratory_syncytial_virus_infection_and_hospitalization__NNT_=_51_
Clesrovimab Reduces Risk of Respiratory Syncytial Virus Infection and Hospitalization (NNT = 51); Unclear if It's Better Than Nirsevimab (CLEVER) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377519/all/Clesrovimab_reduces_risk_of_respiratory_syncytial_virus_infection_and_hospitalization__NNT_=_51_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clesrovimab reduces risk of respiratory syncytial virus infection and hospitalization (NNT = 51); unclear if it's better than nirsevimab (CLEVER)
ID - 3377519
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377519/all/Clesrovimab_reduces_risk_of_respiratory_syncytial_virus_infection_and_hospitalization__NNT_=_51_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
